doi: 10.1002/ppul.1950040408 101 KotasRVAveryME
Recent developments highlight significant momentum in Chinas oral GLP-1 pipeline: On July 15, 2025, Hengrui Medicine announced successful Phase III trial results for HRS9531, a dual GLP-1/GIP receptor agonist
Published pharmacokinetic data are most robust for this route, and the clinical track record is longest
Lipo 3603D is a package of body contouring procedures that removes fat around the entire midsection (front, sides, and back) while also addressing skin tightening and, when desired, fat transfer to enhance the breasts or buttocks
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide that has been widely studied for its relationship to sleep regulation, circadian rhythm activity, and neuroendocrine signaling